{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:10:42Z","timestamp":1791465042877,"version":"4.3.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:00:00Z","timestamp":1661385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:00:00Z","timestamp":1661385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Vitiligo is a prevalent depigmentation disorder affecting around 1% of the general population. So far, various Genome Wide Association Studies (GWAS) and Candidate Gene Association Studies (CGAS) have identified several single nucleotide variants (SNVs) as a risk factor for vitiligo. Nonetheless, little has been discerned regarding their direct functional significance to the disease pathogenesis. In this study, we did extensive data mining and downstream analysis using several experimentally validated datasets like GTEx Portal and web tools like rSNPBase, RegulomeDB, HaploReg and STRING to prioritize 13 SNVs from a set of 291SNVs that have been previously reported to be associated with vitiligo. We also prioritized their underlying\/target genes and tried annotating their functional contribution to vitiligo pathogenesis. Our analysis revealed genes like <jats:italic>FGFR10P<\/jats:italic>, <jats:italic>SUOX, CDK5RAP1 and RERE<\/jats:italic> that have never been implicated in vitiligo previously to have strong potentials to contribute to the disease pathogenesis. The study is the first of its kind to prioritize and functionally annotate vitiligo-associated GWAS and CGAS SNVs and their underlying\/target genes, based on functional data available in the public domain database.<\/jats:p>","DOI":"10.1038\/s41598-022-18766-9","type":"journal-article","created":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T16:03:53Z","timestamp":1661443433000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A comprehensive meta-analysis and prioritization study to identify vitiligo associated coding and non-coding SNV candidates using web-based bioinformatics tools"],"prefix":"10.1038","volume":"12","author":[{"given":"Tithi","family":"Dutta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayantan","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpan","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kausik","family":"Ganguly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tushar","family":"Pyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mainak","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,25]]},"reference":[{"key":"18766_CR1","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3349\/ymj.2015.56.3.719","volume":"56","author":"H Lee","year":"2015","unstructured":"Lee, H. et al. Prevalence of vitiligo and associated comorbidities in Korea. Yonsei Med. J. 56, 719\u2013725 (2015).","journal-title":"Yonsei Med. J."},{"key":"18766_CR2","first-page":"9","volume":"11","author":"Y Zhang","year":"2016","unstructured":"Zhang, Y. et al. The prevalence of vitiligo: A meta-analysis. PLoS One 11, 9 (2016).","journal-title":"PLoS One"},{"key":"18766_CR3","doi-asserted-by":"publisher","DOI":"10.25259\/IJDVL_219_2021","author":"S-K Kim","year":"2022","unstructured":"Kim, S.-K., Kwon, H.-E., Jeong, K.-H., Shin, M. K. & Lee, M.-H. Association between exonic polymorphisms of human leukocyte antigen-G gene and non-segmental vitiligo in the Korean population. Indian J. Dermatol. Venereol. Leprol. 1\u20136. https:\/\/doi.org\/10.25259\/IJDVL_219_2021 (2022). Epub ahead of print.","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"18766_CR4","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1038\/jid.2009.32","volume":"129","author":"RM Luiten","year":"2009","unstructured":"Luiten, R. M. et al. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. J. Invest. Dermatol. 129, 2220\u20132232 (2009).","journal-title":"J. Invest. Dermatol."},{"key":"18766_CR5","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/8498472","volume":"2022","author":"Y Xuan","year":"2022","unstructured":"Xuan, Y., Yang, Y., Xiang, L. & Zhang, C. The role of oxidative stress in the pathogenesis of vitiligo: A culprit for melanocyte death. Oxid. Med. Cell. Longev. 2022, 8498472. https:\/\/doi.org\/10.1155\/2022\/8498472 (2022).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"18766_CR6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s12291-010-0045-7","volume":"26","author":"A Jain","year":"2011","unstructured":"Jain, A., Mal, J., Mehndiratta, V., Chander, R. & Patra, S. K. Study of oxidative stress in vitiligo. Indian J. Clin. Biochem. 26, 78\u201381 (2011).","journal-title":"Indian J. Clin. Biochem."},{"key":"18766_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2021.624517","volume":"12","author":"EL Katz","year":"2021","unstructured":"Katz, E. L. & Harris, J. E. Translational research in vitiligo. Front. Immunol. 12, 1\u201317 (2021).","journal-title":"Front. Immunol."},{"key":"18766_CR8","first-page":"1","volume":"2022","author":"S He","year":"2022","unstructured":"He, S., Xu, J. & Wu, J. The promising role of chemokines in vitiligo: From oxidative stress to the autoimmune response. Oxid. Med. Cell. Longev. 2022, 1\u201310 (2022).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"18766_CR9","doi-asserted-by":"publisher","first-page":"109161","DOI":"10.18632\/oncotarget.22644","volume":"8","author":"J Dong","year":"2017","unstructured":"Dong, J. et al. Interleukin-22 participates in the inflammatory process of vitiligo. Oncotarget 8, 109161\u2013109174 (2017).","journal-title":"Oncotarget"},{"key":"18766_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41702-019-0043-1","volume":"3","author":"P Chiarella","year":"2019","unstructured":"Chiarella, P. Vitiligo susceptibility at workplace and in daily life: The contribution of oxidative stress gene polymorphisms. Biomed. Dermatol. 3, 1\u201312 (2019).","journal-title":"Biomed. Dermatol."},{"key":"18766_CR11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3889\/oamjms.2018.040","volume":"6","author":"S Gianfaldoni","year":"2018","unstructured":"Gianfaldoni, S. et al. Vitiligo in children: A better understanding of the disease. Open Access Maced. J. Med. Sci. 6, 181\u2013184 (2018).","journal-title":"Open Access Maced. J. Med. Sci."},{"key":"18766_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1365-4632.2006.02848.x","volume":"46","author":"T Lu","year":"2007","unstructured":"Lu, T. et al. Vitiligo prevalence study in Shaanxi Province, China. Int. J. Dermatol. 46, 47\u201351 (2007).","journal-title":"Int. J. Dermatol."},{"key":"18766_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/molecules22081303","volume":"22","author":"C Niu","year":"2017","unstructured":"Niu, C. & Aisa, H. A. Upregulation of melanogenesis and tyrosinase activity: Potential agents for vitiligo. Molecules 22, 8 (2017).","journal-title":"Molecules"},{"key":"18766_CR14","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3389\/fgene.2015.00278","volume":"6","author":"T Traks","year":"2015","unstructured":"Traks, T. et al. Polymorphisms in Toll-like receptor genes are associated with vitiligo. Front. Genet. 6, 278 (2015).","journal-title":"Front. Genet."},{"key":"18766_CR15","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2165\/00128071-200203050-00001","volume":"3","author":"CL Huang","year":"2002","unstructured":"Huang, C. L., Nordlund, J. J. & Boissy, R. Vitiligo: A manifestation of apoptosis?. Am. J. Clin. Dermatol. 3, 301\u2013308 (2002).","journal-title":"Am. J. Clin. Dermatol."},{"key":"18766_CR16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jaut.2007.07.012","volume":"29","author":"A Ruiz-Arg\u00fcelles","year":"2007","unstructured":"Ruiz-Arg\u00fcelles, A., Brito, G. J., Reyes-Izquierdo, P., P\u00e9rez-Romano, B. & S\u00e1nchez-Sosa, S. Apoptosis of melanocytes in vitiligo results from antibody penetration. J. Autoimmun. 29, 281\u2013286 (2007).","journal-title":"J. Autoimmun."},{"key":"18766_CR17","doi-asserted-by":"publisher","first-page":"96","DOI":"10.5144\/0256-4947.2022.96","volume":"42","author":"G Saif","year":"2022","unstructured":"Saif, G. Bin & Khan, I. A. Association of genetic variants of the vitamin D receptor gene with vitiligo in a tertiary care center in a Saudi population: A case-control study. Ann. Saudi Med. 42, 96\u2013106 (2022).","journal-title":"Ann. Saudi Med."},{"key":"18766_CR18","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/jcmm.12206","volume":"18","author":"M Becatti","year":"2014","unstructured":"Becatti, M. et al. SIRT1 regulates MAPK pathways in vitiligo skin: Insight into the molecular pathways of cell survival. J. Cell. Mol. Med. 18, 514\u2013529 (2014).","journal-title":"J. Cell. Mol. Med."},{"key":"18766_CR19","doi-asserted-by":"crossref","unstructured":"Zhang, J. et al. Research Progress on Targeted Antioxidant Therapy and Vitiligo. Oxid. Med. Cell. Longev. 2022 (2022).","DOI":"10.1155\/2022\/1821780"},{"key":"18766_CR20","unstructured":"Amadi-myers, A. et al. Variant of. 1\u201312 (2010)."},{"key":"18766_CR21","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/jid.2012.320","volume":"133","author":"XF Tang","year":"2013","unstructured":"Tang, X. F. et al. Association analyses identify three susceptibility loci for vitiligo in the chinese han population. J. Invest. Dermatol. 133, 403\u2013410 (2013).","journal-title":"J. Invest. Dermatol."},{"key":"18766_CR22","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/ng.2272","volume":"44","author":"Y Jin","year":"2012","unstructured":"Jin, Y. et al. Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo. Nat. Genet. 44, 676\u2013680 (2012).","journal-title":"Nat. Genet."},{"key":"18766_CR23","first-page":"526","volume":"44","author":"EM Shajil","year":"2006","unstructured":"Shajil, E. M., Chatterjee, S., Agrawal, D., Bagchi, T. & Begum, R. Vitiligo: Pathomechanisms and genetic polymorphism of susceptible genes. Indian J. Exp. Biol. 44, 526\u2013539 (2006).","journal-title":"Indian J. Exp. Biol."},{"key":"18766_CR24","first-page":"1","volume":"8","author":"M Xu","year":"2018","unstructured":"Xu, M. et al. Genetic polymorphisms of GZMB and vitiligo: A genetic association study based on Chinese Han population. Sci. Rep. 8, 1\u20135 (2018).","journal-title":"Sci. Rep."},{"key":"18766_CR25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.molimm.2020.02.014","volume":"121","author":"D \u00c7a\u011fda\u015f","year":"2020","unstructured":"\u00c7a\u011fda\u015f, D. et al. Autoinflammation in addition to combined immunodeficiency: SLC29A3 gene defect. Mol. Immunol. 121, 28\u201337 (2020).","journal-title":"Mol. Immunol."},{"key":"18766_CR26","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.12659\/MSM.914898","volume":"25","author":"Y Wang","year":"2019","unstructured":"Wang, Y., Li, S. & Li, C. Perspectives of new advances in the pathogenesis of vitiligo: From oxidative stress to autoimmunity. Med. Sci. Monit. 25, 1017\u20131023 (2019).","journal-title":"Med. Sci. Monit."},{"key":"18766_CR27","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1046\/j.1524-4725.1999.99093-2.x","volume":"25","author":"AM Kahn","year":"1999","unstructured":"Kahn, A. M. Surgical treatment of vitiligo [2]. Dermatol. Surg. 25, 669 (1999).","journal-title":"Dermatol. Surg."},{"key":"18766_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers12113119","volume":"12","author":"M Gebert","year":"2020","unstructured":"Gebert, M., Ja\u015bkiewicz, M., Moszy\u0144ska, A., Collawn, J. F. & Bartoszewski, R. The effects of single nucleotide polymorphisms in cancer rnai therapies. Cancers (Basel) 12, 1\u201320 (2020).","journal-title":"Cancers (Basel)"},{"key":"18766_CR29","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/sj.gene.6364243","volume":"6","author":"I Cant\u00f3n","year":"2005","unstructured":"Cant\u00f3n, I. et al. A single-nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptibility to generalised vitiligo. Genes Immun. 6, 584\u2013587 (2005).","journal-title":"Genes Immun."},{"key":"18766_CR30","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.bbrc.2006.05.063","volume":"345","author":"NG Gavalas","year":"2006","unstructured":"Gavalas, N. G. et al. Analysis of allelic variants in the catalase gene in patients with the skin depigmenting disorder vitiligo. Biochem. Biophys. Res. Commun. 345, 1586\u20131591 (2006).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"18766_CR31","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/ajd.12204","volume":"56","author":"J He","year":"2015","unstructured":"He, J. et al. Lack of association between the 389C>T polymorphism (rs769217) in the catalase (CAT) gene and the risk of vitiligo: An update by meta-analysis. Australas. J. Dermatol. 56, 180\u2013185 (2015).","journal-title":"Australas. J. Dermatol."},{"key":"18766_CR32","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/ng.603","volume":"42","author":"C Quan","year":"2010","unstructured":"Quan, C. et al. Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC. Nat. Genet. 42, 614\u2013618 (2010).","journal-title":"Nat. Genet."},{"key":"18766_CR33","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00403-019-01891-3","volume":"311","author":"K Ganguly","year":"2019","unstructured":"Ganguly, K. et al. Meta-analysis and prioritization of human skin pigmentation-associated GWAS-SNPs using ENCODE data-based web-tools. Arch. Dermatol. Res. 311, 163\u2013171 (2019).","journal-title":"Arch. Dermatol. Res."},{"key":"18766_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2021.146027","volume":"809","author":"PS Giri","year":"2022","unstructured":"Giri, P. S., Begum, R. & Dwivedi, M. Meta-analysis for association of TNFA-308(G>A) SNP with vitiligo susceptibility. Gene 809, 146027 (2022).","journal-title":"Gene"},{"key":"18766_CR35","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1101\/gr.118992.110","volume":"21","author":"I Lee","year":"2011","unstructured":"Lee, I., Blom, U. M., Wang, P. I., Shim, J. E. & Marcotte, E. M. Prioritizing candidate disease genes by network-based boosting of genome-wide association data. Genome Res. 21, 1109\u20131121 (2011).","journal-title":"Genome Res."},{"key":"18766_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fgene.2016.00003","volume":"7","author":"C Shen","year":"2016","unstructured":"Shen, C. et al. Genetic susceptibility to vitiligo: GWAS approaches for identifying vitiligo susceptibility genes and loci. Front. Genet. 7, 1\u201312 (2016).","journal-title":"Front. Genet."},{"key":"18766_CR37","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jpsychires.2021.11.040","volume":"145","author":"T Pyne","year":"2022","unstructured":"Pyne, T. et al. Prioritization of human well-being spectrum related GWAS-SNVs using ENCODE-based web-tools predict interplay between PSMC3, ITIH4, and SERPINC1 genes in modulating well-being. J. Psychiatr. Res. 145, 92\u2013101 (2022).","journal-title":"J. Psychiatr. Res."},{"key":"18766_CR38","doi-asserted-by":"publisher","first-page":"183948","DOI":"10.1109\/ACCESS.2019.2960037","volume":"7","author":"MH Rahman","year":"2019","unstructured":"Rahman, M. H. et al. Bioinformatics methodologies to identify interactions between type 2 diabetes and neurological comorbidities. IEEE Access 7, 183948\u2013183970 (2019).","journal-title":"IEEE Access"},{"key":"18766_CR39","first-page":"1","volume":"17","author":"MH Rahman","year":"2020","unstructured":"Rahman, M. H. et al. A network-based bioinformatics approach to identify molecular biomarkers for type 2 diabetes that are linked to the progression of neurological diseases. Int. J. Environ. Res. Public Health 17, 1\u201325 (2020).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"18766_CR40","doi-asserted-by":"publisher","first-page":"D545","DOI":"10.1093\/nar\/gkaa970","volume":"49","author":"M Kanehisa","year":"2021","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Ishiguro-Watanabe, M. & Tanabe, M. KEGG: Integrating viruses and cellular organisms. Nucleic Acids Res. 49, D545\u2013D551 (2021).","journal-title":"Nucleic Acids Res."},{"key":"18766_CR41","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/cei.12096","volume":"173","author":"S Sanchez-Sosa","year":"2013","unstructured":"Sanchez-Sosa, S., Aguirre-Lombardo, M., Jimenez-Brito, G. & Ruiz-Arg\u00fcelles, A. Immunophenotypic characterization of lymphoid cell infiltrates in vitiligo. Clin. Exp. Immunol. 173, 179\u2013183 (2013).","journal-title":"Clin. Exp. Immunol."},{"key":"18766_CR42","doi-asserted-by":"publisher","first-page":"279","DOI":"10.4103\/2229-5178.120637","volume":"4","author":"S Deo","year":"2013","unstructured":"Deo, S., Bhagat, A. & Shah, R. Study of oxidative stress in peripheral blood of Indian vitiligo patients. Indian Dermatol. Online J. 4, 279 (2013).","journal-title":"Indian Dermatol. Online J."},{"key":"18766_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.539","volume":"5","author":"Q Wang","year":"2014","unstructured":"Wang, Q. et al. Stress-induced RNASET2 overexpression mediates melanocyte apoptosis via the TRAF2 pathway in vitro. Cell Death Dis. 5, e1022 (2014).","journal-title":"Cell Death Dis."},{"key":"18766_CR44","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/jidsymp.2015.24","volume":"17","author":"Q Wang","year":"2015","unstructured":"Wang, Q., Wang, X. & Xiang, L. Role and mechanism of RNASET2 in the pathogenesis of vitiligo. J. Investig. Dermatology Symp. Proc. 17, 48\u201350 (2015).","journal-title":"J. Investig. Dermatology Symp. Proc."},{"key":"18766_CR45","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/cdd.2015.105","volume":"23","author":"G Caputa","year":"2016","unstructured":"Caputa, G. et al. RNASET2 is required for ROS propagation during oxidative stress-mediated cell death. Cell Death Differ. 23, 347\u2013357 (2016).","journal-title":"Cell Death Differ."},{"key":"18766_CR46","unstructured":"Younus, H. Younus, H. (2018). Therapeutic potentials of superoxide dismutase. International journal of health sciences, 12(3), 88.\u200f. Int. J. Health Sci. (Qassim). 12, 88\u201393 (2018)."},{"key":"18766_CR47","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.autrev.2014.10.002","volume":"14","author":"M Dwivedi","year":"2015","unstructured":"Dwivedi, M. et al. Regulatory T cells in vitiligo: Implications for pathogenesis and therapeutics. Autoimmun. Rev. 14, 49\u201356 (2015).","journal-title":"Autoimmun. Rev."},{"key":"18766_CR48","doi-asserted-by":"publisher","first-page":"221","DOI":"10.12998\/wjcc.v3.i3.221","volume":"3","author":"GF Mohammed","year":"2015","unstructured":"Mohammed, G. F. Highlights in pathogenesis of vitiligo. World J. Clin. Cases 3, 221 (2015).","journal-title":"World J. Clin. Cases"},{"key":"18766_CR49","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/iji.12476","volume":"47","author":"A Bagheri Hamidi","year":"2020","unstructured":"Bagheri Hamidi, A. et al. Association of MTHFR C677T polymorphism with elevated homocysteine level and disease development in vitiligo. Int. J. Immunogenet. 47, 342\u2013350 (2020).","journal-title":"Int. J. Immunogenet."},{"key":"18766_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11306-021-01843-x","volume":"17","author":"R Marzabani","year":"2021","unstructured":"Marzabani, R. et al. Metabolomic signature of amino acids in plasma of patients with non-segmental Vitiligo. Metabolomics 17, 1\u201311 (2021).","journal-title":"Metabolomics"},{"key":"18766_CR51","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.mehy.2009.02.003","volume":"73","author":"JS Diao","year":"2009","unstructured":"Diao, J. S. et al. Aberrant Notch signaling: A potential pathomechanism of vitiligo. Med. Hypotheses 73, 70\u201372 (2009).","journal-title":"Med. Hypotheses"},{"key":"18766_CR52","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1684\/ejd.2012.1728","volume":"22","author":"MK Shin","year":"2012","unstructured":"Shin, M. K. et al. Association between CDK5RAP1 polymorphisms and susceptibility to vitiligo in the korean population. Eur. J. Dermatology 22, 495\u2013499 (2012).","journal-title":"Eur. J. Dermatology"},{"key":"18766_CR53","doi-asserted-by":"crossref","unstructured":"Colucci, R., Dragoni, F. & Moretti, S. Oxidative stress and immune system in vitiligo and thyroid diseases. Oxid. Med. Cell. Longev. 2015 (2015).","DOI":"10.1155\/2015\/631927"},{"key":"18766_CR54","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s00403-020-02168-w","volume":"313","author":"N Srivastava","year":"2021","unstructured":"Srivastava, N. et al. Dendritic cells sub-sets are associated with inflammatory cytokine production in progressive vitiligo disease. Arch. Dermatol. Res. 313, 759\u2013767 (2021).","journal-title":"Arch. Dermatol. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18766-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18766-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18766-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T17:08:08Z","timestamp":1661447288000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18766-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,25]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["18766"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-18766-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,25]]},"assertion":[{"value":"10 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14543"}}